sequential double-antibody solidphase separation radio-immuno-assay (ria) (Solid Phase Inc)
90
Structured Review
Solid Phase Inc
sequential double-antibody solidphase separation radio-immuno-assay (ria)
Sequential Double Antibody Solidphase Separation Radio Immuno Assay (Ria), supplied by Solid Phase Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/solidphase+radio-immuno-assay/sequential+double+antibody+solidphase+separation+radio+immuno+assay++ria+/pm01326217-3-8-9
Average 90 stars, based on 1 article reviews
Sequential Double Antibody Solidphase Separation Radio Immuno Assay (Ria), supplied by Solid Phase Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/solidphase+radio-immuno-assay/sequential+double+antibody+solidphase+separation+radio+immuno+assay++ria+/pm01326217-3-8-9
Average 90 stars, based on 1 article reviews
sequential double-antibody solidphase separation radio-immuno-assay (ria) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Control:Article Title: Increased serum IgD concentrations in patients with Hodgkin's disease. Article Snippet: Serum IgD concentrations have been determined in twenty-one patients with Hodgkin's disease, in eight patients with non-Hodgkin's lymphomas and in twenty-eight normal (control) individuals by both a RIA Assay:Article Title: Increased serum IgD concentrations in patients with Hodgkin's disease. Article Snippet: Serum IgD concentrations have been determined in twenty-one patients with Hodgkin's disease, in eight patients with non-Hodgkin's lymphomas and in twenty-eight normal (control) individuals by both a Radial Immuno Diffusion:Article Title: Increased serum IgD concentrations in patients with Hodgkin's disease. Article Snippet: Serum IgD concentrations have been determined in twenty-one patients with Hodgkin's disease, in eight patients with non-Hodgkin's lymphomas and in twenty-eight normal (control) individuals by both a |